Zynerba Pharmaceuticals

+$0.03 (+0.81%) As of 4:54 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZYNE and other ETFs, options, and stocks.

About ZYNE

Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions.

CEO
Armando Anido
Employees
26
Headquarters
Devon, Pennsylvania
Founded
2007

ZYNE Key Statistics

Market Cap
154.28M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.86M
High Today
$3.77
Low Today
$3.72
Open Price
$3.75
Volume
127.75K
52 Week High
$9.00
52 Week Low
$3.15

ZYNE Earnings

-$0.78
-$0.52
-$0.26
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure